HAB Pharma and Signature Phytochemicals have merged, creating a consolidated entity with a turnover of Rs600 crore. This strategic move aim...

Erik Fleming, a drug counselor, received a two-year prison sentence. He supplied Matthew Perry with ketamine that led to the actor's death....

In a bold move that positions Zydus at the forefront of the U.S. specialty oncology market, the Indian drug manufacturer has secured a $166...

Eli Lilly is making Alzheimer's a major focus for its future innovations. The company is also expanding its specialty medicine offerings in...

Eli Lilly has introduced Lormalzi in India, a pioneering treatment for Alzheimer's that specifically targets amyloid plaques, a significant...

India’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...

Over a dozen Indian companies have launched generic versions of the GLP1 drug used for diabetes and weight management since the expiry of N...

The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...

In Purba Bardhaman, potato farmers face price caps, weak markets and migration woes. As elections near, discontent simmers, but TMC still a...

The investigation into fake Mounjaro injections has widened beyond NCR after authorities confirmed that part of the seized batch was sent t...

Alembic Pharmaceuticals has received final approval from the US Food and Drug Administration for its generic methotrexate injection, used t...

"The formulation was clinically evaluated in a head-to-head comparative study conducted in India, which established the non-inferiority to ...

Biocon has launched two new biosimilar medicines, Bosaya and Aukelso, in the United States. These drugs treat serious bone conditions. They...

The U.S. Food and Drug Administration has approved a higher dose of Biogen's spinal muscular atrophy drug Spinraza, ⁠the company ⁠said on M...

Natco Pharma and Eris Lifesciences are launching generic semaglutide weight-loss injections. The companies are introducing both vial and pe...

Natco Pharma introduces a new, affordable semaglutide injection in multidose vials. This launch coincides with the patent expiry of the inn...

For instance, some vaccines under the Universal Immunisation Programme (UIP) can be used for about four weeks after the vial is opened (for...